Type 3 deiodinase: role in cancer growth, stemness and metabolism

Deiodinases are selenoenzymes that catalyze thyroid hormones (THs) activation (type 1 and type 2, D1 and D2 respectively) or inactivation (type 3, D3). THs are essential for proper body development and cellular differentiation. Their intra- and extra-cellular concentrations are tightly regulated by...

Full description

Bibliographic Details
Main Authors: Domenico eCiavardelli, Maria eBellomo, Caterina eCrescimanno, Veronica eVella
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-12-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00215/full
_version_ 1818841235376308224
author Domenico eCiavardelli
Domenico eCiavardelli
Maria eBellomo
Caterina eCrescimanno
Veronica eVella
Veronica eVella
author_facet Domenico eCiavardelli
Domenico eCiavardelli
Maria eBellomo
Caterina eCrescimanno
Veronica eVella
Veronica eVella
author_sort Domenico eCiavardelli
collection DOAJ
description Deiodinases are selenoenzymes that catalyze thyroid hormones (THs) activation (type 1 and type 2, D1 and D2 respectively) or inactivation (type 3, D3). THs are essential for proper body development and cellular differentiation. Their intra- and extra-cellular concentrations are tightly regulated by deiodinases with a pre-receptorial control thus generating active or inactive form of THs. Changes in deiodinases expression are anatomically and temporally regulated and influence the downstream TH signaling. D3 overexpression is a feature of proliferative tissues such as embryo or cancer tissues. The enhanced TH degradation by D3 induces a local hypothyroidism thus inhibiting THs transcriptional activity. Of note, overexpression of D3 is a feature of several highly proliferative cancers. In this paper we review recent advances in the role of D3 in cancer growth, stemness and metabolic phenotype. In particular we focus on the main signalling pathways that result in the overexpression of D3 in cancer cells and are known to be relevant to cancer development, progression, and recurrence. We also discuss the potential role of D3 in cancer stem cells metabolic phenotype, an emerging topic in cancer research.
first_indexed 2024-12-19T04:22:51Z
format Article
id doaj.art-12d8fe16247f4f879654fbb1b78a48f4
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-19T04:22:51Z
publishDate 2014-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-12d8fe16247f4f879654fbb1b78a48f42022-12-21T20:36:06ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922014-12-01510.3389/fendo.2014.00215113104Type 3 deiodinase: role in cancer growth, stemness and metabolismDomenico eCiavardelli0Domenico eCiavardelli1Maria eBellomo2Caterina eCrescimanno3Veronica eVella4Veronica eVella5University Kore of EnnaUniversity “G. d’Annunzio” of Chieti-PescaraUniversity Kore of EnnaUniversity Kore of EnnaUniversity Kore of EnnaUniversity of CataniaDeiodinases are selenoenzymes that catalyze thyroid hormones (THs) activation (type 1 and type 2, D1 and D2 respectively) or inactivation (type 3, D3). THs are essential for proper body development and cellular differentiation. Their intra- and extra-cellular concentrations are tightly regulated by deiodinases with a pre-receptorial control thus generating active or inactive form of THs. Changes in deiodinases expression are anatomically and temporally regulated and influence the downstream TH signaling. D3 overexpression is a feature of proliferative tissues such as embryo or cancer tissues. The enhanced TH degradation by D3 induces a local hypothyroidism thus inhibiting THs transcriptional activity. Of note, overexpression of D3 is a feature of several highly proliferative cancers. In this paper we review recent advances in the role of D3 in cancer growth, stemness and metabolic phenotype. In particular we focus on the main signalling pathways that result in the overexpression of D3 in cancer cells and are known to be relevant to cancer development, progression, and recurrence. We also discuss the potential role of D3 in cancer stem cells metabolic phenotype, an emerging topic in cancer research.http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00215/fulldeiodinaseWarburg effectStemnessD3cancer stem cells (CSCs)
spellingShingle Domenico eCiavardelli
Domenico eCiavardelli
Maria eBellomo
Caterina eCrescimanno
Veronica eVella
Veronica eVella
Type 3 deiodinase: role in cancer growth, stemness and metabolism
Frontiers in Endocrinology
deiodinase
Warburg effect
Stemness
D3
cancer stem cells (CSCs)
title Type 3 deiodinase: role in cancer growth, stemness and metabolism
title_full Type 3 deiodinase: role in cancer growth, stemness and metabolism
title_fullStr Type 3 deiodinase: role in cancer growth, stemness and metabolism
title_full_unstemmed Type 3 deiodinase: role in cancer growth, stemness and metabolism
title_short Type 3 deiodinase: role in cancer growth, stemness and metabolism
title_sort type 3 deiodinase role in cancer growth stemness and metabolism
topic deiodinase
Warburg effect
Stemness
D3
cancer stem cells (CSCs)
url http://journal.frontiersin.org/Journal/10.3389/fendo.2014.00215/full
work_keys_str_mv AT domenicoeciavardelli type3deiodinaseroleincancergrowthstemnessandmetabolism
AT domenicoeciavardelli type3deiodinaseroleincancergrowthstemnessandmetabolism
AT mariaebellomo type3deiodinaseroleincancergrowthstemnessandmetabolism
AT caterinaecrescimanno type3deiodinaseroleincancergrowthstemnessandmetabolism
AT veronicaevella type3deiodinaseroleincancergrowthstemnessandmetabolism
AT veronicaevella type3deiodinaseroleincancergrowthstemnessandmetabolism